GW&K Investment Management LLC Acquires 36,911 Shares of Steris PLC (NYSE:STE)

GW&K Investment Management LLC raised its holdings in Steris PLC (NYSE:STE) by 13.5% during the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 309,350 shares of the medical equipment provider’s stock after acquiring an additional 36,911 shares during the quarter. GW&K Investment Management LLC’s holdings in Steris were worth $44,698,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors have also made changes to their positions in STE. Commerce Bank grew its position in shares of Steris by 17.5% during the 2nd quarter. Commerce Bank now owns 2,394 shares of the medical equipment provider’s stock worth $356,000 after buying an additional 357 shares in the last quarter. Quantamental Technologies LLC bought a new position in shares of Steris during the 2nd quarter worth $682,000. WINTON GROUP Ltd grew its position in shares of Steris by 82.0% during the 2nd quarter. WINTON GROUP Ltd now owns 10,479 shares of the medical equipment provider’s stock worth $1,560,000 after buying an additional 4,720 shares in the last quarter. LPL Financial LLC grew its position in shares of Steris by 22.6% during the 2nd quarter. LPL Financial LLC now owns 14,778 shares of the medical equipment provider’s stock worth $2,202,000 after buying an additional 2,729 shares in the last quarter. Finally, TimesSquare Capital Management LLC bought a new position in shares of Steris during the 2nd quarter worth $60,058,000. 88.11% of the stock is currently owned by institutional investors.

Shares of STE traded up $0.65 during midday trading on Friday, reaching $145.84. 278,973 shares of the stock were exchanged, compared to its average volume of 477,181. Steris PLC has a 52 week low of $99.14 and a 52 week high of $156.66. The company has a current ratio of 2.41, a quick ratio of 1.87 and a debt-to-equity ratio of 0.37. The company’s 50 day moving average is $142.12 and its two-hundred day moving average is $143.11. The company has a market capitalization of $12.38 billion, a P/E ratio of 29.82 and a beta of 0.88.

Steris (NYSE:STE) last issued its quarterly earnings data on Monday, November 4th. The medical equipment provider reported $1.32 earnings per share for the quarter, topping analysts’ consensus estimates of $1.26 by $0.06. The firm had revenue of $736.84 million during the quarter, compared to analysts’ expectations of $717.79 million. Steris had a return on equity of 14.28% and a net margin of 11.59%. The firm’s quarterly revenue was up 8.5% on a year-over-year basis. During the same period in the prior year, the business posted $1.10 EPS. On average, sell-side analysts expect that Steris PLC will post 5.61 EPS for the current year.

The business also recently disclosed a quarterly dividend, which will be paid on Friday, December 20th. Investors of record on Tuesday, November 26th will be paid a dividend of $0.37 per share. This represents a $1.48 dividend on an annualized basis and a dividend yield of 1.01%. The ex-dividend date is Monday, November 25th. Steris’s dividend payout ratio (DPR) is currently 30.27%.

Separately, ValuEngine downgraded Steris from a “buy” rating to a “hold” rating in a research report on Wednesday, October 2nd. One analyst has rated the stock with a hold rating and five have issued a buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and an average target price of $148.20.

In related news, VP John Adam Zangerle sold 1,000 shares of the company’s stock in a transaction on Friday, October 4th. The stock was sold at an average price of $142.15, for a total transaction of $142,150.00. Also, VP Renato Tamaro sold 2,065 shares of the company’s stock in a transaction on Wednesday, August 14th. The stock was sold at an average price of $153.15, for a total value of $316,254.75. The disclosure for this sale can be found here. Corporate insiders own 2.36% of the company’s stock.

About Steris

STERIS plc provides infection prevention and other procedural products and services worldwide. The company operates in four segments: Healthcare Products, Healthcare Specialty Services, Life Sciences, and Applied Sterilization Technologies. The Healthcare Products segment offers cleaning chemistries and sterility assurance products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operations of a sterile processing department; and equipment used in the operating room, including surgical tables, lights, equipment management services, and connectivity solutions.

Featured Story: What is a blue-chip stock?

Want to see what other hedge funds are holding STE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Steris PLC (NYSE:STE).

Institutional Ownership by Quarter for Steris (NYSE:STE)

Receive News & Ratings for Steris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Steris and related companies with MarketBeat.com's FREE daily email newsletter.



Comments


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit